Back to top

Anika Therapeutics Inc: (NASD: ANIK)

(U.S: NASD) As of Apr 17, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$39.23 USD

-0.10 (-0.25%)

Volume: 193,857

Zacks Rank : NA [?]

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Quote Overview

Stock Activity

Open 39.03
Day Low 38.00
Day High 40.00
52 Wk Low 12.26
52 Wk High 52.49
Avg. Volume 297,150
Market Cap 563.40 M
Dividend 0.00 ( 0.00%)
Beta 1.73

Key Earnings Data

Forward PE NA
PEG Ratio NA
Current Qtr Est NA
Current Yr Est NA
Most Accurate Est NA
Qtr Earnings ESP[?] 0.00%
Exp Earnings Date 5/7/2014
Prior Year EPS 1.39
Exp EPS Growth NA
Industry MED-BIOMED/GENE

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for ANIK

Zacks Rank [?]
Zacks Industry Rank 83 / 265 (Top 31%)
Equity Research Report No Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
AASTROM BIOSCI ASTM
AMGEN INC AMGN
ANI PHARMACEUT ANIP
MYRIAD GENETICS MYGN
SOLIGENIX INC SNGX
TROVAGENE INC TROV
ZIOPHARM ONCLGY ZIOP
ACTELION LTD ALIOF
AFFYMETRIX INC AFFX
AGENUS INC AGEN

See all MED-BIOMED/GENE Peers>>